Text or WhatsApp Richard at (808) 600-9260
Lion crestHealthcareInvestmentBanking.com

Healthcare Investor Insights from the Family Office Club's Events

In six of the 23 Family Office Club recordings indexed here, an individual speaker names one investor screen each. These are the views of those six speakers, not a survey of market practice. Between them, they want a practicing clinician on the team, sponsor cash at risk, a protected downside, a defined hold period, a clear regulatory path and a founder with a track record. Owners who plan to sell, recapitalize or raise should have an answer to all six before the first call.

This hub indexes the clips by goal and compares six investor mandates. It sets the clips beside market data from CMS, PESP and Kaufman Hall covering 2024 through Q3 2026. It also works three deals in dollars: a PE offer where the owner keeps the building, a $2 million physician raise and a minority recap against a full sale.

Each clip is listed under its published YouTube title, as of November 2026, so you can check it at the source. Speakers are described by the role they state on camera. Clip descriptions are our paraphrases, not verbatim quotes, so watch the clip before attributing a specific claim to a speaker.

Family Office Club Healthcare Clip Index

Clips with a timestamp link to the moment the topic starts. The rest open at the beginning.

Of the 23 clips, six are formal investor mandate interviews, eight are investor panels and talks, four cover PE platforms and minority stakes, three cover selling or scaling a practice and two cover raising money from physicians.

Raising capital from physicians and dentists (2 clips)

Companion guide: Raising capital from physician investors

Recording Speaker role What to listen for
Strategies for Successful Healthcare Investments: Networking with Doctors and Dentists (from 0:50) Panelist and physician investor Why physicians discount pitches from non-clinicians, and what earns their attention
Pitching Doctor Investors Presenter on physician fundraising The gap between physician income and net worth, and which doctors can write a check

PE platforms, roll-ups and minority stakes (4 clips)

Companion guide: PE physician roll-ups

Recording Speaker role What to listen for
Healthcare Bottleneck Panel (from 4:50) Panelist on physician deal structuring Doctor shortage as the growth limit, keeping the real estate, standalone entities
Medical Panel: How Investors, Tech Tools and Platforms Are Evolving (from 16:41) Dentist and practice coach What multi-location platforms offer sellers, patient privacy risk across sites, valuation
Billionaire Healthcare Investor Fireside Chat Healthcare investor and founder Physician practice management and cyclical trends
UK Minority-Stake Healthcare Investor Head of a healthcare investment firm Minority stakes with the operator still in charge

Selling or scaling a practice (3 clips)

Companion guide: Selling a physician practice

Recording Speaker role What to listen for
Scaling a Medical Practice Investor and former healthcare operator Burnout, clerical load and technology as a growth driver
How to Scale, Sell a Business, and be Ultra Healthy and Wealthy Dentist who sold a laser dentistry practice Niche focus, a simple deal presentation, diligence, life after the sale
Where Healthcare Capital Is Going Family office founder (life sciences, practices) Buying practices from retiring doctors

Investor mandate interviews (6 clips)

Companion guide: Family office healthcare investing

Recording Speaker role What to listen for
Healthcare, Telemedicine and Distressed Real Estate SFO Mandate Interview Physician and single family office principal Co-investing, short-duration deals, caution on valuations
Life Sciences SFO Mandate Interview Family office investor Therapeutics co-investment with global partners
Healthcare and Life Sciences Private Investor Mandate Interview Family office principal Early-stage, pre-FDA screening
Life Sciences, Medical Devices and Healthcare Investor Mandate Interview Angel group lead FDA pathway, standard of care, M&A exits
Seed Stage Angel Investor Mandate Interview Angel group representative Referrals and candor with founders
SaaS and Healthcare Investor Mandate Interview Angel investor and managing director Pre-Series A traction, management teams

Investor panels and talks (8 clips)

Recording Speaker role What to listen for
Insider Tips for Investing in Healthcare Healthcare investor How reimbursement models shape returns, physicians as co-investors
Family Office Panel on Health Tech and Devices Panelist and physician investor Performance metrics, regulatory questions
A Physician Family Office on Biotech and AI Physician family office principal Cap table versus fund investing, founder track record
Future of Healthcare Investing Panel Longevity and concierge physician Wearables, AI, concierge medicine
From Doctor to Investor: Protecting Your Downside Physician investor and former OB/GYN Protecting principal in private placements
Multi-Family Office for Doctors and Dentists Multi-family office CEO Private lending, tax-efficient structures
A Physician Investor on Dental and Real Assets Investor and physician Operators with skin in the game
A Principal Who Built and Sold Across Sectors Family office principal Secondaries and discounted stakes

Most of the footage shows what buyers and investors screen for. Sellers can use those clips to preview the questions a buyer's team will ask.

Watch by skill

Skill Clips
Pitching Networking panel (0:50), Pitching Doctor Investors, seed-stage angel mandate
Structuring Bottleneck panel (4:50), UK minority-stake investor, physician family office on cap table versus fund investing
Negotiating a sale Medical panel (16:41), the dentist on scaling and selling
Scaling Scaling a Medical Practice, billionaire healthcare investor fireside chat
Investing as a physician Former OB/GYN on private placements, life sciences angel group, physician investor on dental and real assets

Which Capital Source Fits Your Goal

Start with what you want from the transaction. The capital source follows from that.

Your goal Capital source to study first Relevant clips What you give up
Full liquidity and a planned exit from ownership PE platform or health system buyer Bottleneck panel (4:50), medical panel (16:41), dentist on selling Control, and usually a post-closing employment term
Take some money off the table and keep running the business Minority investor or family office UK minority-stake investor, multi-family office for doctors and dentists A share of future upside, plus investor consent rights
Growth capital for a health tech or telemedicine company Physician SFO, seed and pre-Series A angels Telemedicine SFO, seed-stage angels, SaaS and healthcare angels Equity, and a board seat or reporting obligation
Funding a therapeutic, device or diagnostic program Life sciences angel group or life sciences SFO Life sciences angel group, life sciences SFO, healthcare and life sciences principal Equity, and milestone-driven follow-on terms
Raising a first round from local clinicians Physician and dentist angels Networking panel (0:50), Pitching Doctor Investors Equity spread across many small holders
Buying a practice or funding a build-out without selling equity Bank debt, including the SBA 7(a) program None in this set Fixed debt service and lender covenants
Turning practice real estate into cash or income Separate real estate buyer, or a lease to the operating buyer Bottleneck panel (4:50) Future appreciation if you sell the building

Six Deal-Breakers from Six Clips

Deal-breaker Where it comes up Why it kills the deal What to ask or prepare
A business person pitching with no clinician involved Networking panel at 0:50 Physicians on that panel discount claims from non-physicians Who on your team practices medicine?
Sponsor has no money in the deal Physician investor on dental and real assets If the sponsor cannot lose money, the downside is not shared How much cash has the sponsor invested, and on what terms?
Downside left unprotected Former OB/GYN on private placements That investor makes protecting principal the first test What is the collateral or priority if the plan fails?
Long or undefined hold Physician SFO mandate That principal wants short-duration deals What is the target exit date, and what is the fallback?
No regulatory path Life sciences angel lead That group screens first for an FDA pathway and an M&A exit Which pathway, and which milestones come first?
Thin founder record Physician family office on biotech and AI That speaker gives founder track record heavy weight What has this team built and exited before?

Raising Money from Doctors and Dentists

Just remember that whatever investor set you target is going to have a natural position on these trust curves. So if you're raising a healthcare investment fund or a health tech company and you're only raising capital from doctors, then they're going to be up the learning curve on the industry and maybe on the opportunity.
Richard C. Wilson, Richard C. Wilson mastermind and workshop transcripts (compiled April 2025)

Start with investors who already know the industry, such as dentists backing dental practices. Focus on local physicians and surgeons who can visit the site, and listen before you pitch. Clinicians in your own field need less explanation, so the raise moves faster. The messenger matters as much as the message. List the first three people a physician prospect will meet or hear from. If none of them is a clinician, fix that before outreach starts.

Why physicians distrust business pitches

Family Office Club panel on networking with physician and dentist investors

From 0:50, a physician investor on the panel explains how doctors judge pitches from people outside medicine. Physicians respond to data and to peers who are already involved. Recruit a clinician before you book investor meetings, and open with outcome or utilization data instead of projections.

Which doctors can actually write a check

Family Office Club video on pitching physician investors

The clip argues that high income does not always mean high net worth, so only some doctors are realistic prospects. It covers how to target entrepreneurial physicians, how to respect their limited time and why trusted introductions beat cold outreach. Do not ask prospects for account balances or other detailed financial information. Ask whether they have invested in private deals before, and let your attorney set the investor qualification process. Set your minimum and your target list with that in mind.

A physician raise in five steps

Step What to do Why
1. Build the list Local clinicians in your specialty, then adjacent specialties Peers need less explanation and can visit the site
2. Qualify Ask about private-deal experience, and qualify investors through the process your attorney sets Income alone does not show capacity to absorb a loss
3. Map referrals Note which prospects could refer patients to the business Investors who also refer raise structuring questions to settle with your attorney
4. Set terms Fix the minimum, the use of proceeds and the exit or liquidity plan The clips show investors screening on duration and downside
5. Clear the structure Finish the offering structure review before the first deck goes out Marketing method and investor mix can change how the raise is set up

The local physicians most likely to invest are often the ones most likely to refer. Build the referral map during the raise, not after it, and check it against the healthcare compliance due diligence guide.

Selling to a PE Platform or Family Office

The doctor shortage is the real constraint

Panel on physician bottlenecks and deal structure

From 4:50, the panelists argue that a shortage of excellent doctors limits growth more than patient volume or capital does. They also cover keeping the real estate when you sell, setting up standalone entities for separate income streams and aligning investor and physician goals on continuity of care. Test that claim against your own market before you pitch it. The BLS Health Care and Social Assistance industry page carries current employment and wage data for the sector.

If physicians are the bottleneck, the buyer is paying partly for your future work. Employment terms, non-competes and earnouts tied to your production are standard and negotiable. Treat each one as a deal term and put a price on it.

If you own your building, decide before you sign a letter of intent whether it is part of the sale. Keeping it and leasing it to the buyer creates a second income stream, valued in Scenario 1 below.

Why most deals run through an MSO

PE platforms and family offices buying physician practices often buy a management services organization (MSO) rather than the practice itself. The MSO holds the non-clinical assets and contracts with a physician-owned practice to provide management services. The physician entity keeps the licenses and clinical control, and the MSO collects a management fee. Three terms decide how much value the buyer actually controls: that fee, the succession terms for practice ownership and the limits on transferring practice equity. Read all three before you compare an MSO offer with a direct purchase. Rules on who may own a practice and how fees may be split differ by jurisdiction and can affect structure, so raise them with your own attorney. The MSO guide covers how these structures are built.

What a platform promises the selling doctor

Medical panel on investors, tech tools and multi-location platforms

From 16:41, a dentist and practice coach discusses what multi-location platforms offer doctors who sell to them. Elsewhere in the session, the panel flags patient privacy compliance risk across sites and explains why valuation gets harder as locations are added. Get these answers in writing:

Check the rest of the letter of intent against the LOI and term sheet red flags checklist and the healthcare M&A process guide.

A dentist's account of selling

A dentist on building, scaling and selling a laser dentistry practice

A dentist who built, scaled and sold a laser dentistry practice walks through the sale from the seller's side. The clip covers niche focus, a simple deal presentation, due diligence and life after the exit. Plan what you will do with the proceeds as carefully as you plan the sale. Watch it alongside the practice sale guide.

Six Mandate Interviews Compared

Each row reflects what the investor said on camera. Mandates shift, so confirm the current one before you pitch.

Interview Capital source Stage Sector focus What they screen for Bring to the first call
Telemedicine and health tech SFO Physician single family office Not stage-specific Health tech, telemedicine, AI in insurance Co-investing with experienced families, short-duration deals, its own diligence Named co-investors and a dated exit or liquidity plan
Life sciences SFO Life sciences single family office Therapeutics programs Humanized therapeutics Global co-investment partners Lead investor and syndicate status
Healthcare and life sciences principal Family office principal Early stage, pre-FDA Healthcare and life sciences Rigorous diligence, sectors the office understands A full data room on day one
Life sciences angel group Life sciences angel group Clinical and regulatory stage Therapeutics, devices, diagnostics Strong management, change in standard of care, large markets, M&A exit A regulatory pathway memo and a list of likely acquirers
Seed-stage digital health angels New York angel group Seed Digital health Referrals, candor, US companies, Northeast preferred A warm introduction and plain disclosure of risks
SaaS and healthcare angels South Florida angel group Pre-Series A with traction SaaS and healthcare Management team, strategic value, any location Traction metrics and team bios

Six interviews are enough to sort prospects, not to describe the market. Match on stage first, because a seed company pitching a clinical-stage group wastes both sides' time. Match on capital source second. The family offices here talk about partners and duration. The angel groups talk about team and referral path. Tailor the sector story last.

A physician principal and an angel lead on diligence

Physician single family office principal on a healthcare and telemedicine mandate

A physician who now runs a single family office explains why the office co-invests alongside experienced families, runs its own diligence and stays cautious on current valuations. This principal wants a short hold, so put a dated exit plan in the first deck you send.

Life sciences angel group lead on FDA pathways and exits

The lead of a life sciences angel group screens on three questions. Is there an FDA approval pathway? Could the product change the standard of care? Is there a realistic M&A exit? The lead advises new physician investors to join a group and pool expertise instead of investing alone. The two views fit together. An office with staff and a track record can carry diligence alone. A doctor writing a first private check usually cannot.

What the Market Data Says Beside the Clips

The speakers describe their own mandates. The data below shows where the wider market sits. Each dataset covers a different population and period, so read each row on its own terms and do not compare counts across rows.

Indicator Population and period Figure Source
Total US health spending National health expenditures, calendar 2024 Grew 7.2% to $5.3 trillion, 18.0% of GDP CMS National Health Expenditure fact sheet
Payer shares of spending National health expenditures, calendar 2024 Private insurance about 31%, Medicare about 21%, out of pocket about 11% CMS NHE fact sheet
Projected physician and clinical services growth CMS projection, 2025 through 2034 5.5% a year on average CMS NHE fact sheet
PE-backed healthcare deals All healthcare deals PESP tracked, calendar 2025 1,029 (151 buyouts, 664 add-ons, 214 growth investments) PESP, Private Equity Healthcare Deals: 2025 in Review
Platforms and firms involved Same PESP 2025 dataset 420 platform companies, 708 investment firms PESP, 2025 in Review
Outpatient care deals PESP outpatient subset, calendar 2025, from a secondary report by Becker's ASC Review, so treat as indicative 148, including 119 add-ons PESP data reported by Becker's ASC Review
Top outpatient subsectors by deal count PESP outpatient subset, calendar 2025 Dermatology 24, eye care 22, oncology 9 PESP data reported by Becker's ASC Review
Hospital transactions announced, 2026 Hospitals and health systems, Q1, Q2 and Q3 2026 22, 18 and 16, for 56 through September 30, 2026, as reported by Becker's from Kaufman Hall data Kaufman Hall data reported by Becker's Hospital Review
Hospital transactions announced, 2025 Hospitals and health systems, full calendar 2025 46, as reported by Becker's Kaufman Hall data reported by Becker's Hospital Review
Transacted revenue Hospital and health system deals announced in Q3 2026 $8.2 billion in total, with average seller size that "approached $586 million" Kaufman Hall Q3 2026 M&A report, October 13, 2026
Hospital operating margin Hospitals in Kaufman Hall's data, year to date through August 2026 2.5% including allocations, with nearly 43% of hospitals operating at a loss Kaufman Hall Q3 2026 M&A report, October 13, 2026

Demand is not the constraint. Per the CMS National Health Expenditure fact sheet, physician and clinical services spending grew faster in 2024 than total US health spending, which grew 7.2% to $5.3 trillion. CMS projects physician and clinical services spending to grow 5.5% a year on average from 2025 through 2034. That supports the bottleneck panel's point. Patient volume is there, and the scarce input is clinicians. Medicare paid 21% and private insurance 31% of 2024 spending, so expect a buyer to ask how your own payer mix compares and how each contract rate is trending.

PE still runs on add-ons. In PESP's 2025 count, 664 of 1,029 PE healthcare deals were add-ons. By our arithmetic on the PESP counts, that is 64.5%, with growth investments at 20.8% and buyouts at 14.7%. The tilt was stronger in PESP's 2025 outpatient subset as reported by Becker's ASC Review, where 119 of 148 deals (80.4%, our arithmetic) were add-ons. Dermatology's 24 deals were 16.2% of that outpatient total and eye care's 22 were 14.9%, also our arithmetic. If a PE-backed buyer calls, it is more likely an existing platform shopping for an add-on than a new investor. Ask early how many add-ons it has closed.

Physician groups remain a core PE holding. In "New Models of Value Creation for Physician Groups," part of its Global Healthcare Private Equity Report 2026, Bain & Company writes that physician groups remain a major part of many PE portfolios despite the decline in deal volumes from their peak. The same article names nephrology, plastic surgery and behavioral health as specialties drawing interest. None of the six mandate interviews above names those three specialties. Those mandates lean toward telemedicine, health tech and life sciences. Owners in Bain's three specialties should expect PE platforms to make most of the calls.

Hospital buyers are active but under margin pressure. Kaufman Hall, as reported by Becker's Hospital Review, counted 56 hospital transactions announced in the first nine months of 2026 and 46 in all twelve months of 2025. That compares unequal periods, so it is not a growth rate, and Q4 2026 had not been reported as of November 20, 2026. The like-for-like comparison is the quarter. The 16 deals announced in Q3 2026 matched Q3 2025, per Kaufman Hall's October 13, 2026 report. That report counts two megamergers in Q3 2026, the third straight quarter with deals of that size, and says 2026 could set a record for deals in which the smaller party has more than $1 billion in annual revenue. Not-for-profits made up most Q3 acquirers, and divestitures were nearly one-third of announced deals.

Cite the Q3 revenue figures exactly as Kaufman Hall states them. Dividing $8.2 billion by 16 deals gives about $513 million per deal (our arithmetic), below the reported $586 million average seller size, so the reported average is not a simple total-over-count figure.

Margins stayed thin. Year to date through August 2026, Kaufman Hall reports non-labor expenses per adjusted discharge up 6% over 2025, with supply expenses up 5% and drug expenses up 6%. A practice or outpatient business selling to a health system should expect the buyer to price cost risk tightly.

Three Scenarios with Our Arithmetic

These are illustrative scenarios, not forecasts. All inputs are hypothetical, the assumptions sit beside each table and every output is our arithmetic on those assumptions. The results depend heavily on the assumed rent collection, investor conversion rate, discount rate and deal terms, so rerun them with your own figures before relying on any number.

Scenario 1: a dermatology group owner contacted by a PE-backed platform

Dermatology had the most outpatient deals, 24, in PESP's 2025 data as reported by Becker's ASC Review, so this owner may get more than one call. Watch the bottleneck panel at 4:50 and the dentist's account of selling, then run your own figures in the deal proceeds calculator.

Assumptions: cash-free and debt-free sale. Escrow is withheld from the non-contingent price. No transaction fees, taxes or working capital adjustments. The lease is triple net (the tenant pays property taxes, insurance and maintenance), rent is paid at each year end and the base case assumes the tenant pays every year of the term.

Input Value
Revenue $10 million
EBITDA (normalized for owner pay) $1.4 million
Headline offer, including earnout $8 million
Earnout portion of headline $1.6 million
Escrow 10% of the non-contingent price
Rollover equity None
Real estate Owner keeps the building and leases it to the buyer at $300,000 a year for 10 years
Measure Calculation Result
Headline multiple $8,000,000 ÷ $1,400,000 About 5.7x EBITDA
Non-contingent price $8,000,000 less $1,600,000 $6,400,000
Non-contingent multiple $6,400,000 ÷ $1,400,000 About 4.6x EBITDA
EBITDA margin $1,400,000 ÷ $10,000,000 14%
Escrow held back 10% × $6,400,000 $640,000
Cash at closing $8,000,000 less $1,600,000 less $640,000 $5,760,000, or 72% of headline
Lease, nominal $300,000 × 10 years $3,000,000 outside the purchase price
Lease, present value at 6% $300,000 × 7.3601 About $2.21 million
Lease, present value at 8% $300,000 × 6.7101 About $2.01 million
Lease, present value at 10% $300,000 × 6.1446 About $1.84 million
Downside: tenant leaves after year 5, building empty for years 6 to 10, at 8% $300,000 × 3.9927 About $1.20 million

The downside row prices vacancy risk. At an 8% discount rate, losing the last five years of rent cuts the lease value from $2,013,030 to $1,197,810, a drop of about $815,000 (our arithmetic). The lease values exclude income tax, capital repairs the landlord still carries and any renewal after year 10. A gross lease, where the owner pays property costs, would lower every present value. Use a higher discount rate if the tenant's credit is weak or the building is specialized.

Ask for the buyer's EBITDA bridge before comparing offers, and reconcile its margin with yours. The valuation multiples guide covers benchmarks by specialty, and the earnout value calculator weights the earnout for probability. Escrow size, base and release dates are all negotiated.

The headline price, the cash at closing and the total value of the relationship are three different numbers. In this case they are $8.0 million, $5.76 million and $8.0 million plus a lease worth $1.84 million to $2.21 million depending on the discount rate. Work out all three before you answer a letter of intent.

Scenario 2: a founder raising $2 million from physicians

Watch the networking panel at 0:50 and Pitching Doctor Investors, then read the physician investor guide.

Assumptions: every investor writes exactly the minimum, the founder holds three investor meetings a week and commitments convert at a fixed rate. Weeks are rounded up to whole weeks. Real raises mix check sizes, and conversion varies between warm and cold introductions, so treat the timelines as planning ranges.

Step At a $100,000 minimum At a $200,000 minimum
Investors needed $2,000,000 ÷ $100,000 = 20 $2,000,000 ÷ $200,000 = 10
Meetings needed at 1 commitment per 4 meetings 20 × 4 = 80 10 × 4 = 40
Weeks of meetings at 1 in 4 80 ÷ 3 = 26.7, so 27 40 ÷ 3 = 13.3, so 14
Meetings needed at 1 commitment per 5 meetings 20 × 5 = 100 10 × 5 = 50
Weeks of meetings at 1 in 5 100 ÷ 3 = 33.3, so 34 50 ÷ 3 = 16.7, so 17
Each investor's share of the round 5% 10%
Investor relationships to manage after closing 20 10

Doubling the minimum halves the meeting count and cuts the calendar by 13 weeks at the 1 in 4 rate and 17 weeks at the 1 in 5 rate. It also shrinks the pool to physicians who can put $200,000 into one private deal, which is the income versus net worth point the Pitching Doctor Investors clip makes. Each investor at the higher minimum holds twice the share of the round, so each departure or dispute matters more. Fix the minimum and the outreach method together. The capital raising guide frames those choices, and the securities questions it raises belong with your own attorney.

Scenario 3: a minority recapitalization versus a full sale

The UK minority-stake investor clip describes stakes where the operator stays in charge.

Assumptions: equity value of $8 million today (cash-free and debt-free). A family office buys 30% of the owner's existing shares for $2.4 million in cash, paid to the owner, and the whole company sells five years later. The investor takes no liquidation preference or preferred return. Pre-tax, no fees, no further dilution.

Exit equity value in year 5 Owner's 70% at exit Plus $2.4M taken today Owner's undiscounted total Versus selling 100% today for $8M
$6,000,000 $4,200,000 $2,400,000 $6,600,000 $1,400,000 less
$8,000,000 $5,600,000 $2,400,000 $8,000,000 Even
$12,000,000 $8,400,000 $2,400,000 $10,800,000 $2,800,000 more

The undiscounted table flatters the minority path, because most of the proceeds arrive five years later. Discount the year 5 proceeds at 10% a year (factor 0.6209) and the break-even moves. The owner's 70% must be worth $5.6 million in today's dollars to match a full sale. That requires an exit equity value of about $12.9 million ($5,600,000 ÷ 0.7 ÷ 0.6209, our arithmetic), or growth in equity value of about 61% over five years before the minority deal wins.

The minority path pays off only if the owner expects that growth and wants to keep running the company for the hold period. A liquidation preference would lower the owner's total in every downside case. Ask for the preference terms, the investor's target hold and the consent rights before comparing the two paths.

A Diligence Checklist Built from the Investor Clips

Have these ready before you raise or invest. Use the list with the buyer due diligence checklist and the guide to vetting a buyer or investor.

In the private placement clip, the former OB/GYN gives the investor's version of the same list: protect the downside, demand transparency and ask sponsors direct questions. Sellers can see the same questions from the buyer's side in the sale readiness guide.

The Adviser Bench to Assemble Before the First Meeting

The clips show investors arriving with their own diligence teams. Match them with yours before the first meeting, not after the letter of intent. The figures below come from the three scenarios above.

Adviser When to bring them in What to hand them What you should get back
Healthcare transaction attorney Before outreach for a raise, or before you sign a letter of intent for a sale Referral map, investor target list, draft deck, any existing MSO or lease agreements A structure review and a list of filings, consents and open questions
CPA or tax adviser As soon as the first offer arrives The Scenario 1 split: $5,760,000 cash at closing, $640,000 escrow, $1,600,000 earnout and a $300,000 annual lease What you keep after tax from each component, under each structure on the table
Quality of earnings provider Before you share EBITDA with any buyer Normalized EBITDA ($1.4 million in Scenario 1) and every owner pay adjustment A sell-side EBITDA bridge to reconcile against the buyer's
Real estate appraiser or broker Before deciding whether the building is part of the sale Proposed lease terms, building condition, the tenant's credit Market rent and a value for keeping versus selling the building
Investment banker or intermediary When you expect several bidders, or are raising from institutions The mandate table above, filtered to investors that match your stage A qualified buyer or investor list and a process timeline
Wealth adviser or multi-family office Before closing Expected proceeds and timing, such as $2.4 million today and the balance in year 5 in Scenario 3 A plan for the proceeds, the point the dentist's clip makes about life after the sale

Before you pay anyone a fee to introduce investors or find a buyer, look up the firm and the individual on FINRA BrokerCheck and read how to choose a healthcare investment banker.

Where the Scenario 1 Dollars Sit and Who Guards Each One

An $8 million headline is really four payments with different timing and different risks. Map each one to the adviser who protects it, so no part of the offer goes unreviewed.

Component Amount When it reaches you What can shrink it Who reviews it
Cash at closing $5,760,000 (72% of headline) At closing Closing adjustments the letter of intent leaves open, which Scenario 1 assumes away CPA and quality of earnings provider
Escrow $640,000 (10% of the $6.4 million non-contingent price) On the negotiated release dates Buyer claims paid out of the escrow before release Transaction attorney and CPA
Earnout $1,600,000 (20% of headline) After the earnout period, only if targets are met Missed targets, or EBITDA and production definitions written by the buyer Quality of earnings provider, with the earnout value calculator
Building lease $3,000,000 nominal, about $1.84 million to $2.21 million in present value $300,000 a year for 10 years A tenant leaving after year 5 drops the 8% value to about $1.20 million Real estate appraiser or broker

Read the table top to bottom before you negotiate. Only the first row is certain on closing day. Together the escrow and earnout put $2,240,000, or 28% of the headline, at risk after you hand over the keys. Each 1 point of escrow on this deal moves $64,000, so trading a lower escrow percentage against a longer release period is a concrete number you can put in front of the buyer.

Physician investors who refer, leases between a selling owner and the buyer, and MSO structures raise the questions covered in the healthcare compliance due diligence guide, and deal size or a serial add-on strategy can bring in the reviews covered in the healthcare M&A process guide. Take the questions those pages raise to your own attorney before the deck goes out or the letter of intent is signed.

Three habits separate prepared sellers and founders from the rest:

  1. Give every adviser the same numbers. One model, one EBITDA figure and one cap table, shared across the bench, prevent contradictions an investor will find.
  2. Finish the structure review before the deck goes out. A deck that has already gone to 80 physicians cannot be recalled if the structure changes.
  3. Price each adviser against the deal. A 10% escrow on $6.4 million is $640,000 at risk. Spending to protect it is a business decision, not overhead.

Questions Practice Owners and Investors Ask

What do family offices look for in healthcare investments?

Each office sets its own mandate, and mandates change. In six Family Office Club mandate interviews, a physician single family office principal targets telemedicine and health tech, prefers short-duration deals and co-invests with experienced families. A healthcare and life sciences principal screens early-stage, pre-FDA companies. A life sciences office looks for global co-investment partners. The angel groups focus on management teams, referral paths and exit routes. Match on stage first and capital source second, and confirm the current mandate before you pitch.

How do you raise capital from doctors and dentists?

Start with physicians who already know your field and live close enough to visit the site. Listen before you pitch, lead with outcome or utilization data and put a practicing clinician on your team. Ask about private-deal experience rather than income, let your attorney set the investor qualification process and set your minimum check size with that in mind. Settle how you will market the raise, and map which physician investors could also refer patients, before outreach starts.

What due diligence questions should I expect from a family office investor?

Investors in Family Office Club recordings ask for written answers to a standard due diligence questionnaire, a one-pager and a short pitch. They also want a data room built for your industry and stage, audited financials, a clear exit or derisking path, proof that the sponsor has real equity at risk and, where possible, collateral such as receivables or equipment. Life sciences investors also ask about the FDA pathway and whether the product changes the standard of care.

Sources